152 related articles for article (PubMed ID: 20583384)
1. Monitoring the coverage and impact of human papillomavirus vaccine - report of WHO meeting, November 2009.
Wkly Epidemiol Rec; 2010 Jun; 85(25):237-43. PubMed ID: 20583384
[No Abstract] [Full Text] [Related]
2. Cost-effectiveness analysis of introducing universal human papillomavirus vaccination of girls aged 11 years into the National Immunization Program in Brazil.
Novaes HM; de Soárez PC; Silva GA; Ayres A; Itria A; Rama CH; Sartori AM; Clark AD; Resch S
Vaccine; 2015 May; 33 Suppl 1():A135-42. PubMed ID: 25919154
[TBL] [Abstract][Full Text] [Related]
3. Correlates of human papillomavirus vaccine coverage: a state-level analysis.
Moss JL; Reiter PL; Brewer NT
Sex Transm Dis; 2015 Feb; 42(2):71-5. PubMed ID: 25585064
[TBL] [Abstract][Full Text] [Related]
4. Latin America. Price is the main barrier to wider use of papillomavirus vaccine.
Kaiser J
Science; 2008 May; 320(5878):860. PubMed ID: 18487164
[No Abstract] [Full Text] [Related]
5. [Swedish consensus on cervix cancer vaccination. Vaccination programs for eradication of HPV16/18 should be initiated in elementary schools].
Dillner J; Andrae B; Westermark B
Lakartidningen; 2006 Nov 1-7; 103(44):3377-9. PubMed ID: 17152260
[No Abstract] [Full Text] [Related]
6. Evaluating human papillomavirus vaccination programs.
Donovan B; Guy RJ
Sex Transm Dis; 2013 Apr; 40(4):290-1. PubMed ID: 23481536
[No Abstract] [Full Text] [Related]
7. Cost-effectiveness analysis of the introduction of the human papillomavirus vaccine in Honduras.
Aguilar IB; Mendoza LO; García O; Díaz I; Figueroa J; Duarte RM; Perdomo G; Garcia AG; Janusz CB
Vaccine; 2015 May; 33 Suppl 1():A167-73. PubMed ID: 25919157
[TBL] [Abstract][Full Text] [Related]
8. HPV vaccine: implications for nurses and patients.
Schmidt JV
Nurs Womens Health; 2007 Feb; 11(1):83-7. PubMed ID: 17883822
[No Abstract] [Full Text] [Related]
9. The announcement by the GAVI Alliance Board to support human papillomavirus (HPV) vaccines in the world's poorest countries.
Vaccine; 2012 Nov; 30 Suppl 4():xii. PubMed ID: 23510773
[No Abstract] [Full Text] [Related]
10. Human papillomavirus, vaccines and women's health: questions and cautions.
Lippman A; Melnychuk R; Shimmin C; Boscoe M
CMAJ; 2007 Aug; 177(5):484-7. PubMed ID: 17671239
[No Abstract] [Full Text] [Related]
11. European Centre for Disease Prevention and Control issues guidance for the introduction of human papillomavirus (HPV) vaccines in European Union countries.
Hamers FF;
Euro Surveill; 2008 Jan; 13(4):. PubMed ID: 18445398
[No Abstract] [Full Text] [Related]
12. An extended cost-effectiveness analysis of publicly financed HPV vaccination to prevent cervical cancer in China.
Levin CE; Sharma M; Olson Z; Verguet S; Shi JF; Wang SM; Qiao YL; Jamison DT; Kim JJ
Vaccine; 2015 Jun; 33(24):2830-41. PubMed ID: 25770785
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis of a cervical cancer vaccine in five Latin American countries.
Colantonio L; Gómez JA; Demarteau N; Standaert B; Pichón-Rivière A; Augustovski F
Vaccine; 2009 Sep; 27(40):5519-29. PubMed ID: 19616499
[TBL] [Abstract][Full Text] [Related]
14. Assessing the introduction of universal human papillomavirus vaccination for preadolescent girls in The Netherlands.
Boot HJ; Wallenburg I; de Melker HE; Mangen MJ; Gerritsen AA; van der Maas NA; Berkhof J; Meijer CJ; Kimman TG
Vaccine; 2007 Aug; 25(33):6245-56. PubMed ID: 17630049
[TBL] [Abstract][Full Text] [Related]
15. Preventing cervical cancer : overviews of the National Breast and Cervical Cancer Early Detection Program and 2 US immunization programs.
Khan K; Curtis CR; Ekwueme DU; Stokley S; Walker C; Roland K; Benard V; Saraiya M
Cancer; 2008 Nov; 113(10 Suppl):3004-12. PubMed ID: 18980296
[TBL] [Abstract][Full Text] [Related]
16. The estimated impact of human papillomavirus vaccine coverage on the lifetime cervical cancer burden among girls currently aged 12 years and younger in the United States.
Chesson HW; Ekwueme DU; Saraiya M; Dunne EF; Markowitz LE
Sex Transm Dis; 2014 Nov; 41(11):656-9. PubMed ID: 25299411
[TBL] [Abstract][Full Text] [Related]
17. Controlling cervical cancer.
Bonati M; Garattini S
Pharmacoeconomics; 2009; 27(2):91-3. PubMed ID: 19254043
[No Abstract] [Full Text] [Related]
18. Model-based impact and cost-effectiveness of cervical cancer prevention in the Extended Middle East and North Africa (EMENA).
Kim JJ; Sharma M; O'Shea M; Sweet S; Diaz M; Sancho-Garnier H; Seoud M
Vaccine; 2013 Dec; 31 Suppl 6():G65-77. PubMed ID: 24331822
[TBL] [Abstract][Full Text] [Related]
19. [HPV-infection].
Schmidt-Petruschkat S
MMW Fortschr Med; 2007 Mar; 149(12):29-31. PubMed ID: 17674887
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus vaccines: WHO position paper, May 2017.
Wkly Epidemiol Rec; 2017 May; 92(19):241-68. PubMed ID: 28530369
[No Abstract] [Full Text] [Related]
[Next] [New Search]
